Erratum to: Diabetes Ther (2015) 6:317–328 DOI: 10.1007/s13300-015-0119-x
The authors wish to make corrections to the article.
The third sentence of the “Patient Disposition and Demographics” subsection within the “Results” section should read:
“For metformin and sulfonylurea, 72% and 74% of patients also had HbA1c assessed at week 52.”
The third paragraph of the “Predictive Parameters” subsection within the “Results” section should read:
“The predictive parameters for improvements in HbA1c for week 24, based on the composite unified early-response measure (reduction in HbA1c level of ≥1.0% or HbA1c level of <7.0%) for metformin were 0.83, 0.81, 0.44, and 0.96; for sulfonylurea, 0.79, 0.94, 0.71, and 0.96; and for insulin glargine, 0.67, 0.89, 0.65, and 0.90.”
Within the footnote to Table 5, the optimal early-response measure should be defined as:
“HbA1c reduction of ≥1.0% for sulfonylurea and glargine at week 24 and for sulfonylurea at week 52, HbA1c reduction of ≥0.8% for metformin at week 24, and HbA1c reduction of ≥0.6% for metformin at week 52”.
Open Access
This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
Author information
Authors and Affiliations
Corresponding author
Additional information
The online version of the original article can be found under doi:10.1007/s13300-015-0119-x.
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0), which permits use, duplication, adaptation, distribution, and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
About this article
Cite this article
Fu, H., Cao, D., Boye, K.S. et al. Erratum to: Early Glycemic Response Predicts Achievement of Subsequent Treatment Targets in the Treatment of Type 2 Diabetes: A Post hoc Analysis. Diabetes Ther 6, 651 (2015). https://doi.org/10.1007/s13300-015-0132-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13300-015-0132-0